title: Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancer.
authors.affiliation: a Department of Medicine, Division of Medical Oncology , University of Washington , Seattle , WA , USA.|b Fred Hutchinson Cancer Research Institute, Clinical Research Division , Seattle , WA , USA.
authors.forename: M T
authors.initials: MT
authors.lastname: Schweizer
authors.affiliation: c Department of Medicine and GRECC VAPSHCE , University of Washington , Seattle , WA , USA.
authors.forename: S R
authors.initials: SR
authors.lastname: Plymate
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D014408:Biomarkers, Tumor; D016503:Drug Delivery Systems; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D008297:Male; D058990:Molecular Targeted Therapy; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000628:therapy*; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism*; D011944:Receptors, Androgen / Q000235:genetics / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D020033:Protein Isoforms; D011944:Receptors, Androgen
keywords: Androgen receptor; drug resistance; prostate cancer; splice variants